Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

ITCI 11.19.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-03
Name of Upcoming Event:Evercore 7th Annual HealthCONx Conference
Date of Upcoming Event:2024-12-04
Name of Upcoming Event:Citi 2024 Global Healthcare Conference
Date of Upcoming Event:2024-12-05
Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference
Full Press ReleaseSEC FilingsOur ITCI Tweets

About Gravity Analytica

Recent News

  • 01.13.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - Johnson & Johnson Strengthens Neuroscience Leadership with Acquisition of Intra-Cellular Therapies, Inc.
  • 01.10.2025 - Intra-Cellular Therapies Settles CAPLYTA® (lumateperone) Patent Litigation with Sandoz

Recent Filings

  • 01.22.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
  • 01.13.2025 - EX-99.1 EX-99.1
  • 01.13.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
PDF Version

BEDMINSTER, N.J.,Nov. 19, 2024(GLOBE NEWSWIRE) --Intra-Cellular Therapies, Inc.(Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced thatSharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:

Evercore 7th AnnualHealthCONx ConferenceTuesday, December 3, 2024at10:50 a.m. ETinMiami, FL

Citi 2024 Global Healthcare ConferenceWednesday, December 4, 2024at3:15 p.m. ETinMiami, FL

Piper Sandler 36th Annual Healthcare ConferenceThursday, December 5, 2024at11:30 a.m. ETinNew York, NY

A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website atwww.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapiesis a biopharmaceutical company founded onNobelprize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visitwww.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President, Corporate Communications and Investor Relations646-440-9333

Burns McClellan, Inc.Cameron Radinoviccradinovic@burnsmc.com646-930-4406

Primary Logo

Source: Intra-Cellular Therapies, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com